Nas Targeted Spot Treatment

Description

BURT'S BEES Natural Acne Solutions Targeted Spot Treatment is a topical formulation designed for the management of acne. This product contains salicylic acid, a well-known acne treatment ingredient, and is enhanced with soothing cica to provide additional skin comfort. The formulation is designed to penetrate and clear clogged pores, initiating action upon application. With a composition that is 99.9% of natural origin, this treatment is presented in a dosage form of 0.26 fluid ounces (7.68 milliliters).

Uses and Indications

This drug is indicated for the treatment of acne, including the clearance of acne blemishes, acne pimples, blackheads, and whiteheads.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects mentioned.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the product. The product should be applied as a thin layer directly over the blemish, with a recommended frequency of one to three times per day.

It is advised to begin treatment with one application daily to assess tolerance. Based on the patient's response, the frequency may be increased to two or three times daily, as needed or directed by a physician. Care should be taken to avoid the eye area; in the event of contact, the area should be rinsed thoroughly with water.

In cases where excessive dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to mitigate these effects.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of swallowing the product, immediate medical assistance or contact with a Poison Control Center is necessary.

Warnings and Precautions

For external use only. The application of this medication may lead to skin irritation and dryness, particularly if used concurrently with other topical acne treatments. In the event of irritation, it is advised that only one topical medication be utilized unless otherwise directed by a healthcare professional.

This product should be kept out of reach of children to prevent accidental ingestion. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended without delay.

Side Effects

Patients using this medication should be aware that it is for external use only. The application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is advised that only one topical medication be utilized unless otherwise directed by a healthcare professional.

In the event of accidental ingestion, patients are urged to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to avoid the simultaneous application of multiple topical acne treatments. In cases where irritation occurs, the use of only one medication should be considered unless otherwise directed by a healthcare professional. Monitoring for signs of skin irritation is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Nas Targeted Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For application, it is advised to start with one application daily to minimize the risk of excessive dryness. Depending on the patient's response, the frequency may be increased to two or three times daily as directed by a healthcare professional. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been specifically evaluated for use during pregnancy. There are no explicit warnings or contraindications regarding its use in pregnant patients. Additionally, the prescribing information does not provide any dosage modifications for individuals who are pregnant. Furthermore, no special precautions concerning the use of this product during pregnancy are mentioned. Healthcare professionals should consider the lack of specific data when prescribing this product to pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions mentioned regarding lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the individual patient's liver status when prescribing this medication.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct light exposure. To maintain product integrity, it is essential to keep the container tightly closed when not in use. Additionally, any remaining product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer covering the blemish one to three times daily. Patients should begin with one application per day, increasing to two or three times daily as necessary or as directed by a healthcare professional. In cases where bothersome dryness or peeling occurs, it is advised to reduce the frequency of application to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Nas Targeted Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)